Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2006, Vol. 4 ›› Issue (2): 211-214.doi: 10.3736/jcim20060222

• Literature Review • Previous Articles     Next Articles

Correlation between blood pressure variability and target organ damage in patients with hypertension: Research progress and strategies

Yong-gang Wang, Xi Huang   

  1. Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China
  • Online:2006-03-20 Published:2006-03-15

Key words: Blood pressure variability, Hypertension, Target organ damage, Compound prescription, Drugs, Chinese herbal, Therapeutic drug monitoring

CLC Number: 

  • R544.1
[1] Parati G, Pomidossi G, Albini F , et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension[J]. Hypertens, 1987,5(1):93-98
[2] Parati G . Blood pressure variability: its measurement and significance in hypertension[J]. J Hypertens Suppl, 2005,23(1):S19-S25
doi: 10.1007/s11906-006-0051-6 pmid: 15821447
[3] Zhao ZY, Zhao ZY, Wang YQ , et al. Quantitative study of circadian variations ambulatory blood pressure in Chinese healthy, hypertensive, and diabetes subjects[J]. Clin Exp hypertens, 2005,27(2-3):187-194
[4] Eto M, Toba K, Akishita M , et al. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension[J]. Hypertens Res, 2005,28(1):1-7
[5] Su DF, Miao CY . Blood pressure variability and organ damage[J]. Clin Exp Pharmacol Physiol, 2001,28(9):709-715
doi: 10.1046/j.1440-1681.2001.03508.x pmid: 11553028
[6] Miao CY, Yuan WJ, Su DF . Comparative study of sinoaortic denervated rats and spontaneously hypertensive rats[J]. Am J Hypertens, 2003,16(7):585-591
[7] Shen FM, Zhu GM, Miao CY , et al. ATP-sensitive potassium channels are involved in adenosine-induced reduction of blood pressure variability in spontaneously hypertensive rats[J]. J Cardiovasc Pharmacol, 2004,44(1):87-92
[8] El-Mas MM, Abdel-Rahman AA . Chronic ethanol administration attenuates imidazoline Ⅰ1 receptor- or alpha 2-adrenoceptor-mediated reductions in blood pressure and hemodynamic variability in hypertensive rats[J]. Eur J Pharmacol, 2004,485(1-3):251-262
[9] Sollers JJ 3rd, Merritt MM, Silver RA, et al.Understanding blood pressure variability: spectral indices as a function of gender and age[J].Biomed Sci Instrum , 2005, 41(): 43-47
[10] Jacob HJ, Barres CP, Machado BH , et al. Studies on neural and humoral contributions to arterial pressure lability[J]. Am J Med Sci, 1988,295(4):341-345
doi: 10.1097/00000441-198804000-00021 pmid: 3284353
[11] Mancia G, Parati G . The role of blood pressure variability in end-organ damage[J]. J Hypertens Suppl, 2003,21(6):S17-S23
[12] Mena L, Pintos S, Queipo NV , et al. A reliable index for the prognostic significance of blood pressure variability[J]. J Hypertens, 2005,23(3):505-511
[13] 张海燕, 张虎祥, 魏宗德 . 高血压病患者血压波动性与左房功能的关系[J]. 温州医学院学报, 2003,33(6):371-373
doi: 10.3969/j.issn.1000-2138.2003.06.005
[14] Pepperell JC . Stroke and blood pressure variability[J]. Clin Sci, 2004,107(1):27-28
doi: 10.1042/CS20040102 pmid: 15096094
[15] Sander D, Kukla C, Klingelhofer J , et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis——A 3-year follow-up study[J]. Circulation, 2000,102(13):1536-1541
[16] Mancia G, Parati G, Hennig M , et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis(ELSA)[J]. J Hypertens, 2001,19(11):1981-1989
[17] Frattola A, Parati G, Castiglioni P , et al. Lacidipine and blood pressure variability in diabetic hypertensive patients[J]. Hypertension, 2000,36(4):622-628
doi: 10.1161/01.HYP.36.4.622 pmid: 11040246
[18] Pringle E, Phillips C, Thijs L , et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population[J]. J Hypertens, 2003,21(12):2251-2257
[19] Turkington PM, Bamford J, Wanklyn P , et al. Effect of upper airway obstruction on blood pressure variability after stroke[J]. Clin Sci (Lond), 2004,107(1):75-79
doi: 10.1042/CS20030404 pmid: 14992680
[20] Gomez-Angelats E, de La Sierra A, Sierra C , et al. Blood pressure variability and silent cerebral damage in essential hypertension[J]. Am J Hypertens, 2004,17(8):696-700
doi: 10.1016/j.amjhyper.2004.05.002 pmid: 15323065
[21] Cicconetti P, Costarelia M, Moise A , et al. Blood pressure variability and cognitive function in older hypertensives[J]. Arch Gerontol Geriatr Suppl, 2004,( 9):63-68
doi: 10.1016/j.archger.2004.04.011 pmid: 15207398
[22] Sakai M, Tamura K, Tanaka Y , et al. Analysis of factors that affect short-term blood pressure variability in patients with chronic renal failure[J]. Clin Exp hypertens, 2005,27(2-3):139-147
[23] 钱之玉 . 抗高血压药物的评价与研究进展[J]. 药学进展, 2004,28(4):145-148
[24] 严灿, 高敏, 邓中炎 , 等. 高血压病左心室肥厚患者血浆P物质水平的变化及活血祛痰治法的影响[J]. 中国中西医结合杂志, 1998,18(6):336-338
doi: 10.7661/CJIM.1998.6.336
[25] 张金国, 高东升, 魏广和 , 等. 黄芪注射液对急性心肌梗死早期患者左室重塑及心功能的影响[J]. 中国中西医结合杂志, 2002,22(5):346-348
doi: 10.3321/j.issn:1003-5370.2002.05.007
[26] 张群豪, 钟蓓, 陈可冀 , 等. 用血清药理学方法观察血府逐瘀浓缩丸对实验性动脉粥样硬化家兔主动脉平滑肌细胞增殖的影响[J]. 中国中西医结合杂志, 1996,16(3):156-159
[27] 史载祥, 黄柳华 . 高血压及相关疾病中西医结合诊治(第1版)[M]. 北京: 人民卫生出版社, 2003,( 第1版):201-202
[28] 黄熙, 任平 . 防治高血压及冠心病的难点与突破口:方剂的治疗药物监测[J]. 中国中西医结合杂志, 1997,17(9):515-518
doi: 10.7661/CJIM.1997.9.515
[29] 黄熙, 马援 ,将永培 , 等."证治药动学"假说的科学依据和前景. 见: 陈可冀主编. 迈向21世纪的中西医结合. 北京:中国医药科技出版社, 1997,207-2016.
[30] 黄熙 . 方剂体内/血清成分谱与靶成分概念的提出及意义[J]. 第四军医大学学报, 1999,20(4):277-279
doi: 10.3321/j.issn:1000-2790.1999.04.001
[1] Shuai Chen, Jin Hu, Deng-cheng Lu, Hong-yi Liu, Shan-shan Wei. Metabolomic characteristics of spontaneously hypertensive rats under chronic stress and the treatment effect of Danzhi Xiaoyao Powder, a traditional Chinese medicine formula. Journal of Integrative Medicine, 2022, 20(1): 73-82.
[2] Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.
[3] Rakhi Chakraborty, Swarnendu Roy. Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. Journal of Integrative Medicine, 2021, 19(6): 478-492.
[4] Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466.
[5] Qing-lan Wang, Yan-yan Tao, Hong-dong Xie, Cheng-hai Liu, Ping Liu. Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis. Journal of Integrative Medicine, 2020, 18(6): 505-513.
[6] Ming-sheng Lyu, De-ying Li, Shao-zhong Zhou, Cheng-jun Ban, Jun Yan. Adult-onset Still's disease successfully treated with Chinese herbal medicine: A case report with 15-month follow-up. Journal of Integrative Medicine, 2020, 18(6): 530-534.
[7] Arthur Yin Fan, Sherman Gu, Sarah Faggert Alemi, Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(5): 385-394.
[8] Bin Lan, Jin-wen Ge, Shao-wu Cheng, Xi-long Zheng, Jun Liao, Chao He, Zheng-qing Rao, Guo-zuo Wang. Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. Journal of Integrative Medicine, 2020, 18(4): 344-350.
[9] Deng-hai Zhang, Kun-lun Wu, Xue Zhang, Sheng-qiong Deng, Bin Peng. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 2020, 18(2): 152-158.
[10] Pranay Soni, Rajesh Choudhary, Surendra H. Bodakhe. Effects of a novel isoflavonoid from the stem bark of Alstonia scholaris against fructose-induced experimental cataract. Journal of Integrative Medicine, 2019, 17(5): 374-382.
[11] Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106.
[12] Carola Analía Torres, Cristina Marisel Pérez Zamora, María Beatriz Nuñez, Ana María Gonzalez. In vitro antioxidant, antilipoxygenase and antimicrobial activities of extracts from seven climbing plants belonging to the Bignoniaceae. Journal of Integrative Medicine, 2018, 16(4): 255-262.
[13] Shui-jie Shen, Yong-hong Zhang, Xiao-xia Gu, Shui-ju Jiang, Ling-jun Xu. Yangfei Kongliu Formula, a compound Chinese herbal medicine, combined with cisplatin, inhibits growth of lung cancer cells through transforming growth factor-β1 signaling pathway. Journal of Integrative Medicine, 2017, 15(3): 242-251.
[14] Liliana Zazueta-Beltrán, Lorena Medina-Aymerich, Nadia Estela Díaz-Triste, Aracely Evangelina Chávez-Piña, Gilberto Castañeda-Hernández, Leticia Cruz-Antonio. Evidence against the participation of a pharmacokinetic interaction in the protective effect of single-dose curcumin against gastrointestinal damage induced by indomethacin in rats. Journal of Integrative Medicine, 2017, 15(2): 151-157.
[15] Tom Fleischer, Tung-Ti Chang, Hung-Rong Yen. Post-hematopoietic stem cell transplantation in patients with hematologic disorders: Chinese herbal medicine for an unmet need. Journal of Integrative Medicine, 2016, 14(5): 322-335.
Full text



[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239